Forbes: Meet The Direct-To-Consumer CBD Company Seeking To Change The Industry
Cannabidiol (CBD), one of more than 100 compounds found in the cannabis plant, is popping up seemingly everywhere: from food and drink to beauty products. Shopping for CBD, whether for consumers new to the product or experimenting with different options to determine the best fit for them, can be confusing and overwhelming––especially if you don’t know what you’re looking for. Enter Highline Wellness.
New York City-based Highline Wellness is a premium, direct-to-consumer CBD company launched earlier this year by co-founders Chris Roth and Chris D'Alberti. They launched with three products: CBD drops ($44.99-$84.99), chews ($34.99) and pain cream ($34.99), with a mission “to change the way consumers purchase broad spectrum CBD products” by offering an accessible, high-quality product backed by lab results. They offer free 2-day shipping nationwide and $4.99 same-day shipping to Manhattan and Brooklyn.
I spoke with Roth about CBD: what it is, the biggest misconceptions about it, and how Highline Wellness differentiates itself from the increasingly saturated market of CBD products. Here are the top takeaways from our chat:
Not all CBD is created equal
During the process of creating Highline, Roth tried several CBD products that had no effect on him, an occurrence that happens all too often for the uninformed consumer that purchases CBD online or from a wellness store without digging deeper into the company that makes it.
“We’re trying to explain to people that [CBD is] not all made the same,” Roth told me. “It comes down to how the hemp is grown and extracted... And If you take shortcuts, the quality of the product will reflect that.”
April 30, 2019